Home›Stock Screener›Bacil Pharma

Bacil Pharma Share Price Today | Stock Price & Bacil Pharma Share Screener

BACPHAR Pharmaceuticals
Live Share Price BSE
₹27.27
▼ -0.01 (-0.04%)
2026-10-05 00:00:00

As of October 5, 2026, the live Bacil Pharma share price (BSE: BACPHAR) is ₹27.27, down 0.04% from the previous close, with shares trading between ₹27.00 and ₹28.60 in today's trading session, and a 52-week range of ₹11.21–₹59.89. Check BACPHAR annual price range for the annual price range and momentum. Use the Bacil Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Bacil Pharma opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Bacil Pharma Market Cap ₹39.26 Cr.
BACPHAR P/E Ratio (TTM) 56.67
Bacil Pharma P/B Ratio 1.49
EPS (TTM) ₹1.11
Dividend Yield -
Debt to Equity -
BACPHAR 52 Week High ₹59.89
Bacil Pharma 52 Week Low ₹11.21
Operating Margin -
Profit Margin -
BACPHAR Revenue (TTM) -
EBITDA -
Net Income ₹1.00
Total Assets ₹27.00
Total Equity ₹25.00

Bacil Pharma Share Price Chart

Track the current stock price of Bacil Pharma with an interactive chart. Analyse BACPHAR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Bacil Pharma stock quote in one place.

The quote of ₹27.27 sits between the 52-week low of ₹11.21 and the 52-week high of ₹59.89, and the latest session moved -0.04% from the previous close.

Bacil Pharma Company Profile - Fundamental Screener

Screen Bacil Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BACPHAR shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE711D01018.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE711D01018

Bacil Pharma Balance Sheet Screener

Screen BACPHAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹27, up from ₹26 in 2025.

Latest statistics put total assets at ₹27 and shareholder funds at ₹25.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 27 26 1 1 1 4 4 5 5 7
Current Assets 2 3 0 0 0 0 0 1 1 0
Fixed Assets 0 0 0 0 0 3 3 3 3 6

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 25 25 1 1 1 1 1 2 2 6
Share Capital 14 14 7 7 7 7 7 7 7 7
Reserves & Surplus 11 12 -5 -5 -5 -5 -5 -5 -4 0

Bacil Pharma Income Statement Screener - Profit & Revenue Analysis

Screen Bacil Pharma income statement and profit fundamentals. Analyze BACPHAR quarterly results. Bacil Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹1, equal to earnings per unit of ₹0.70.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹1 and net profit of ₹2.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 0 1 1 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 4 0 1 0 0 0 0 0

Operating Costs and Margins

EBITDA 0 1 0 0 0 -4 0 0 0 0 0 0 0
Operating Profit % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 1 0 0 0 -4 0 0 0 -4 0 0 0
Tax 0 -1 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 2 0 0 0 -4 0 0 0 -4 0 0 0
EPS 0.70 1.11 0.64 -0.10 -0.17 -6.55 -0.41 -0.54 -0.58 -6.37 0.00 -0.11 -0.05

Bacil Pharma Cash Flow Screener - Liquidity Fundamentals

Screen BACPHAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹1, and net cash flow was an outflow of ₹2.

Over the same period, investing activities used ₹2 and financing activities used ₹1.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 1 0 0 0 -4 0 0 0 1 0
Investing Activities -2 0 0 0 4 1 0 0 -1 0

Financing and Net Cash

Financing Activities -1 2 0 0 0 0 0 0 0 0
Net Cash Flow -2 3 0 0 0 0 0 0 0 0

Bacil Pharma Shareholding Pattern Screener

See Bacil Pharma shareholding pattern with promoter, FII, and DII holdings. Check Bacil Pharma promoter holding and ownership changes for BACPHAR on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 0.00%, foreign institutions 0.00%, domestic institutions 0.00% and the public 98.26%, spread across 7,226 shareholders.

The shareholder count was 7,226 in 2026-Mar, compared with 7,326 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Jul 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 0.00% 0.00% 0.20% 0.20% 0.08% 0.08% 0.08% 42.67%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 98.26% 95.77% 75.77% 77.37% 79.74% 80.95% 80.95% 53.89%
Other Holding 1.74% 4.23% 24.03% 22.43% 20.18% 18.97% 18.97% 3.44%
Shareholder Count 7,226 7,326 7,638 7,532 7,541 7,431 7,431 6,770

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Bacil Pharma. Bacil Pharma dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Bacil Pharma.

Bacil Pharma Stock Index Membership - Nifty & Sensex

See which indices include Bacil Pharma stock. Check BACPHAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Bacil Pharma is not part of any tracked indices.
Only major market indices are tracked in our system.

Bacil Pharma Market Events Screener - Corporate Actions

Get Bacil Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Bacil Pharma stock events that may affect BACPHAR share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 23, 2026, with a record date of September 23, 2026.

It is followed by Quarterly Result Announcement dated August 12, 2026 and Quarterly Result Announcement dated May 22, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-23 2026-09-23 Annual General Meeting NA 94.83%
2026-08-12 2026-08-12 Quarterly Result Announcement NA -18.45%
2026-05-22 2026-05-22 Quarterly Result Announcement NA -5.53%
2026-02-13 2026-02-13 Quarterly Result Announcement NA 7.69%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -6.67%
2025-09-29 2025-09-29 Annual General Meeting NA 15.34%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -0.21%
2025-05-26 2025-05-26 Quarterly Result Announcement NA 0.00%
2025-01-21 2025-01-21 Quarterly Result Announcement NA -8.02%
2024-11-14 2024-11-14 Extraordinary General Meeting NA 26.52%
2024-10-23 2024-10-23 Quarterly Result Announcement NA 10.34%
2024-09-27 2024-09-27 Annual General Meeting NA 31.36%

Bacil Pharma Competitors Screener - Peer Stocks Comparison

Screen BACPHAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 432,120 36.04 61,674 12.69% 11,565 36.68
Divis Laboratories 245,532 84.24 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 181,333 84.71 13,886 20.34% 2,138 41.12
Zydus Life Science 114,284 25.27 27,658 17.64% 5,026 47.64
Cipla 108,576 32.50 29,045 2.24% 3,870 34.78
Laurus Labs 107,198 98.20 6,868 22.01% 890 58.70
Mankind Pharma 104,707 50.04 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,679 32.41 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,479 25.84 34,145 5.56% 3,503 50.30
Lupin 92,885 16.82 29,039 26.75% 5,356 31.59

Bacil Pharma Company Announcements - News & Reports Screener

Screen BACPHAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 28, 2026.

The next most recent announcements are dated September 26, 2026 and September 23, 2026.

Date Update Actions
2026-09-28 Closure of Trading Window -
2026-09-26 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-23 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-31 Reg. 34 (1) Annual Report. -
2026-08-29 Notice Of Annual General Meeting To Be Held On 23Rd September 2026 -
2026-08-29 Intimation For Book Closure -
2026-08-29 Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th August 2026 -
2026-08-26 Board Meeting Intimation for Bacil Pharma Limited ("The Company") Will Be Held On 29Th August 2026 -
2026-08-25 Appointment Of Director -
2026-08-25 Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th August 2026 -
2026-08-17 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 25Th August 2026 -
2026-08-12 Un-Audited Financial Results For The Quarter Ended 30Th June 2026 -
2026-08-12 Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August 2026 -
2026-08-06 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12Th August 2026 -
2026-07-28 Announcement Under Regulation 30 LODR -
2026-07-18 Attached Resignation Of Directors As Query Raised From BSE -
2026-07-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-10 Announcement under Regulation 30 (LODR)-Change in Management -
2026-07-09 Announcement under Regulation 30 (LODR)-Change in Management -
2026-07-09 Announcement under Regulation 30 (LODR)-Raising of Funds -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹27.27, within a 52-week range of ₹11.21 to ₹59.89. The P/E ratio is 56.67 and the P/B ratio is 1.49, with earnings per unit of ₹1.11. Market capitalisation stands at ₹39.26 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.